Wealth Solutions Report outlines post-LOI pitfalls that can erode RIA sale value

After a letter of intent is signed, an RIA founder's desk fills with documents nobody spent a career learning to read, and Wealth Solutions Report's October 5 piece takes up that stretch with a blunt framing: for most founders, signing the LOI feels like the finish line, when in many ways it is the moment the real work begins. What follows, it argues, can be one of the most demanding parts of an M&A transaction — hundreds of pages of documents, provisions being negotiated for the first time, decisions whose financial and personal consequences run for years.

Set against the rest of the piece's warnings, the closing date is less an administrative milestone than a term of the purchase price. Pulling it forward compresses the window in which consents are collected and clients are reassured, which moves more of the seller's consideration into the contingent column — the earn-out, the retention payment, the second check that clears only if the book holds after the handoff. The implication points one way: if affirmative consents and a working transition are what those payments are measured against, then the consent timeline is a better anchor for the calendar than a quarter-end or a year-end is. The piece stops short of putting it that way, but the warning only has force if sequence matters.

The tradeoffs involved are not legal questions with a right answer: by the time an LOI is signed the banker has run the process and the lawyer will paper the terms, but the choice between a marginally worse structure and a date that holds belongs to one person, and there is exactly one seller at the table. It is also the first stretch of the deal in which the founder is doing the negotiating rather than being sold to, which may be why the mistakes pile up there.

Equity is the second hazard the piece names, and the one a founder is most likely to underprice. Stock in the buyer can be attractive, particularly when the founder believes in the growth of the combined business, but new equity is not necessarily equivalent to the equity the founder owns today: the rights, restrictions, valuation methodologies and liquidity differ. Meaningful skin in the game after closing can be a source of alignment rather than a problem — the piece says as much — but the founder should know how much risk is being retained and how much of the consideration is certain rather than dependent on future outcomes, because two offers carrying the same announced price can leave a seller with very different exposure, and the legal review does not resolve that comparison.

Diligence gets a section of its own. The section opens by conceding a point it says founders often raise, without specifying which, before landing on the observation that a clean business can still have complicated diligence. A firm that has operated a long time accumulates agreements, employees, clients, entities and historical decisions, and issues can surface during representations and warranties even when nobody did anything wrong. A founder who has never had a dispute tends to treat that record as a defense, but the piece's version runs closer to the reverse: the longer the history, the longer the list of things that has to stand behind the number.

The mindset shift the piece saves for last is the one that outlives the closing: an M&A transaction, in its framing, is not simply a legal negotiation but the beginning of a relationship. Buyer and seller may spend months negotiating risk allocation, employment terms, earn-outs and representations, and the piece as published stops mid-sentence on the note that there will inevitably be moments when the process tests that relationship, so its account of those moments is not available. The frame makes the earlier warnings cohere: consent timelines, employment terms, earn-out measures and representations are all provisions whose value depends on how two parties behave toward each other once the deal is done.

For a founder preparing to sell, what remains is a short list of questions that are mostly about time. How long does it take to collect affirmative consents across this book? When do the retention payments begin to vest, and against what measure? What share of the announced price is still contingent the day the wire clears? Those answers are what the closing date is actually negotiating. The advice to value the structure over the speed is cheap to accept in October and expensive to hold at the end of a quarter.